OBJECTIVE: To review the pathophysiology of atherosclerosis, the role of the renin— angiotensin system in atherogenesis, and studies supporting the potential beneficial effects …
CM White - American journal of health-system pharmacy, 2000 - academic.oup.com
The use of angiotensin-converting-enzyme (ACE) inhibitors in patients with heart failure and after myocardial infarction (MI) is discussed, and results of relevant studies are reviewed. In …
K Swedberg, N Sharpe - European heart journal, 1996 - researchgate.net
Angiotensin converting enzyme (ACE) inhibitors have been introduced for the treatment of heart failure within the last decade. Their potential value was suggested by studies showing …
An increasing number of ACE inhibitors have become available in recent years. Because these agents are all similar. careful scrutiny is required in order to determine specific …
P Di Pasquale, L Valdes, V Albano… - Journal of …, 1997 - journals.lww.com
It has been reported that endothelin-1 (ET-1) increases in acute myocardial infarction (AMI). Experimental studies showed that captopril administration reduces ET-1 secretion. In …
AD Michaels, C Maynard, NR Every… - The American journal of …, 1999 - Elsevier
This study was undertaken to examine recent trends in the use of angiotensin-converting enzyme (ACE) inhibitors within 24 hours of admission in patients hospitalized for acute …
K Ueshima, K Fukami, K Hiramori, S Hosoda… - American heart …, 2004 - Elsevier
BACKGROUND: Although angiotensin-converting enzyme (ACE) inhibitors have appeared to be useful for secondary prevention after acute myocardial infarction (AMI) in Western …
Factors predisposing the older person with acute myocardial infarction (MI) to develop heart failure (HF) include an increased prevalence of prior MI and multivessel coronary artery …